Endocrine Society GUIDELINES Bundle (free trial)

Condenital Adrenal Hyperplasia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302964

Contents of this Issue

Navigation

Page 14 of 17

15 Table 5. Utility of Various Analytes for Monitoring CAH Treatment Patients Analyte Physiology Goals and Comments All ages Plasma renin Volume status Low to normal unless hypertensive Potassium MC replacement Goal is normal Sodium GC and MC replacement Goal is normal Testosterone Total androgens Goal is at or near normal Androstenedione Mostly adrenal origin Goal is at or near normal Sex hormone– binding globulin Testosterone- binding protein For calculation of free and bioavailable testosterone 17OHP Variable Normal values indicate overtreatment Men Testosterone Adrenal or ovarian origin Interpret abnormal values in context of gonadotropins and androstenedione levels Gonadotropins Gonadal axis status Low indicates poor control Androstenedione Mainly adrenal Goal is <0.5× testosterone Semen analysis Fertility Goal is normal Women Follicular-phase progesterone Mainly adrenal origin when elevated Goal is <0.6 ng/mL (<2 nmol/L) for women trying to conceive

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Condenital Adrenal Hyperplasia